Recall Record

Birmingham, N/A, United Kingdom

The Binding Site Group, Ltd. recalls

15 recalls recorded since 2018, most recently on 16 April 2026. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls15
Ongoing (FDA)1
Terminated or completed14
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
16 April 2026
Reason
It was reported that plates 2 and 3 were marked as passed , although it appeared that QC had not been performed on these plates, despite samples being measured. The potential clinical hazards include false or missed detection of M-protein (false positive); and falsely elevated or decreased M-protein concentration.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2362-2026

Terminated Class II Medical devices

Recall started
15 October 2021
Terminated
4 February 2025
Reason
Due to calibration curves producing a higher activity than routinely expected and that there may be a decrease in separation between calibrator point 5 and calibrator point 6, which can be exacerbated with calibrator 6 activity reaches the optical ceiling of the SPA+ analyzer.
Distribution
U.S.: CA, CO, FL, IL, IN, KY, LA, MI, NY, OK, SD, TX and VA. O.U.S.: Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-0274-2022

Terminated Class II Medical devices

Recall started
20 May 2021
Terminated
4 February 2025
Reason
The high and low level "Quality Controls" demonstrate a positive bias of approximately 10% compared to assigned values.
Distribution
Worldwide distribution - US Nationwide distribution in the states of CA, GA, FL, MA, MO, MI, WA, NY, PA, MN, AL, MD, OK, NE, IN, ID, OH, TX, HI, DC and the countries of Canada, Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Italy, Luxembou
Initiated
Voluntary: Firm initiated
Recall number
Z-2030-2021

Terminated Class II Medical devices

Recall started
18 November 2020
Terminated
23 December 2024
Reason
Due to customer complaints of positive bias impacting quality control. The high and low level controls are demonstrating a positive bias compared to assigned values.
Distribution
U.S.: CO, FL, IA, MA, NC, NJ, NY, OH, SD, and UT. O.U.S.: Not provided
Initiated
Voluntary: Firm initiated
Recall number
Z-0943-2021

Terminated Class II Medical devices

Recall started
9 April 2020
Terminated
19 August 2022
Reason
A software issue that may affect the analyzer's result accuracy.
Distribution
US Nationwide distribution including in the states of AL, AR, CA, FL, IL, IN, KS, KY, MA, MN, NC, NE, OH, PA, TX and VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2071-2020

Terminated Class II Medical devices

Recall started
6 November 2019
Terminated
8 September 2022
Reason
It has been identified that the rheumatoid factor (RF) calibrator values over recover in comparison to the reference material RF serum. This could result in reporting falsely abnormal results which may lead to unnecessary additional serological testing.
Distribution
Distributed in CA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1500-2020

Terminated Class II Medical devices

Recall started
7 October 2019
Terminated
11 January 2022
Reason
Assigned Rheumatoid Factor (RF) calibrator value for calibrator component included in kit used to aid in the diagnosis of rheumatoid arthritis over recovers by 7% in comparison to the reference material RF serum. This could result in reporting abnormal (false positive) results, which may lead to unnecessary additional serological testing and a delay in treatment.
Distribution
US: AL, AR, AZ, FL, GA, KY, MA, MD, MI, MN, MS, NC, NE, NY, OR, PA, TX, VT, WA, WI OUS: None
Initiated
Voluntary: Firm initiated
Recall number
Z-2110-2020

Terminated Class II Medical devices

Recall started
29 July 2019
Terminated
13 January 2022
Reason
There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in potential false patient results which could cause a delay until repeat testing is performed.
Distribution
CA, PA, FL, AR, SD, MA, WV, AL, GA, IL, MN, MD, AZ, NC, TN, WA, MI, NY, KY, SC, IN, OR, NE, OH, TX, VT, WA, UT, IA,
Initiated
Voluntary: Firm initiated
Recall number
Z-1327-2020

Terminated Class II Medical devices

Recall started
25 April 2019
Terminated
27 April 2021
Reason
A reagent in C reactive protein kits is not performing to specification and samples with known concentrations less-than-or-equal to 10 mg/L may be affected
Distribution
U.S.: FL
Initiated
Voluntary: Firm initiated
Recall number
Z-1619-2020

Terminated Class II Medical devices

Recall started
19 February 2019
Terminated
27 April 2021
Reason
Deterioration of C-reactive protein (CRP) reagent in Optilite C-Reactive Protein Kits
Distribution
US Nationwide distribution in the states of CA and GA. OUS not provided due to product being manufacture OUS
Initiated
Voluntary: Firm initiated
Recall number
Z-0671-2020

Terminated Class II Medical devices

Recall started
6 November 2018
Terminated
27 April 2021
Reason
Firm is offering advice to customers experiencing challenges when validating the calibration curve of the IgM kits. This is indicated by kit control values reporting outside the specified ranges.
Distribution
U.S Distribution to states of: CA, IL, PA, FL, NE, WA, IN, NY, SD and VA,
Initiated
Voluntary: Firm initiated
Recall number
Z-0604-2019

Terminated Class II Medical devices

Recall started
12 August 2018
Terminated
20 January 2022
Reason
A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely elevated results incorrectly indicating a protective level of anti-Hib antibody in the assessment of immunodeficiency.
Distribution
Worldwide distribution - US Nationwide distribution in the states of M.A., C.A., MO., NC, MN, VA, WA, and IL and country of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-1469-2020

Terminated Class II Medical devices

Recall started
25 July 2018
Terminated
27 April 2021
Reason
After running the calibration curve, the recovery of the IgM kit control results decrease demonstrating a reduction in accuracy within the same day; control results may be out of range one day after running the assay calibration curve. Samples have been shown to be similarly affected.
Distribution
U.S.: IL, WV, NE, SD, NY, IN, WA, MD, NJ, PA, NC, AR, FL, VA
Initiated
Voluntary: Firm initiated
Recall number
Z-0477-2019

Terminated Class II Medical devices

Recall started
9 March 2018
Terminated
22 June 2020
Reason
The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.
Distribution
US Distribution was made to CA. There was no foreign/military/government distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1301-2018

Terminated Class II Medical devices

Recall started
4 January 2018
Terminated
9 June 2020
Reason
The low and high controls for the product are returning results above the assigned values.
Distribution
US Distribution was made to CA. There was no foreign/military/government distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0553-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.